Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
Condition: Crohn Disease Intervention: Drug: Infliximab Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: China Health | Crohn's Disease | Inflammatory Bowel Disease | Marketing | Pediatrics | Remicade | Research | Study